Enrollment Closed Archives

Pfizer mRNA Flu Vaccine

A Phase III, multicenter, clinical trial to evaluate the efficacy, safety, tolerability, and immunogenicity of the Pfizer quadrivalent modified RNA (modRNA) influenza vaccine candidate

A Phase II Randomized, Open-label, Multicenter, Dose-ranging Study in adults and pediatric individuals 12 years of age and older to assess the safety, immunogenicity, pharmacokinetics, and pharmacodynamics of AZD7442, a combination of two Monoclonal Antibodies (Tixagevimab and Cilgavimab), for pre-exposure prophylaxis (prevention) of COVID-19

RSV-MVA-004

A Randomized, Double-blind, Phase III trial to assess clinical efficacy, safety and reactogenicity of the recombinant MVA-BN® RSV vaccine in adults 60-years of age and older

#2019-01 C4591031

A Phase 3 Master Protocol to evaluate additional dose(s) of BNt162b2 in healthy 12 to 30 year old individuals previously vaccinated with BNt162b2

IIT-2017-10117

A pilot study for Allergan's intravenous antibiotic, Dalvance® (dalbavancin), administered every 14 days for the treatment of Septic Arthritis (2 infusions) and / or Osteomyelitis (3 infusions)

Microbiome Therapeutics Development

A Phase 3 Open-Label Clinical Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection Read More at Micobiome.Ferring.com Read More at Rebiotix News Informed Consent Disclosure

C4591001

A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, Immunogenicity, and efficacy of SARS-CoV-2 RNA vaccine candidates against COVID-19 in healthy individuals.